Volpo Pharmaceutical Private Limited, a active private limited company, was established on 09 February 1984 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74899DL1984PTC017519. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.47 M.
Formerly known as Volpo Life Sciences Private Limited, East African (India) Remedies Private Limited. It upholds a compliant status. Its leadership includes Saurabh Jain (Director), Ram Kumar Jain (Additional Director). Past directors included Ram Kumar Jain, Santosh Jain, Deepak Kumar Mishra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-30, Ground Floor Vishal Enclave, New Delhi, Delhi, 110027.
U74899DL1984PTC017519
017519
09 February 1984
₹5.00 M
₹0.47 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Volpo Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saurabh Jain | Director | 01 Mar 2017 | Current |
| Ram Kumar Jain | Additional Director | 10 Jun 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2017 | Past |
| Pramod Abcsdd | Director | 01 Mar 2017 | Past |
| Pramod Abcsdd | Director | 10 Jun 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
East African India Overseas Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 6540% increase in profit. The company's net worth Soared by an impressive increase of 132.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Volpo Pharmaceutical had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Volpo Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Volpo Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Volpo Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Volpo Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ram Kumar Jain was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2024 & has been associated with this company since 1 year 5 months . was documented.
Progress on Volpo Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Saurabh Jain was appointed as a Director was appointed as a Director on 01 Mar 2017 & has been associated with this company since 8 years 9 months . was completed.
The activity Volpo Pharmaceutical Private Limited was registered on 09 Feb 1984 with Roc Delhi & aged 41 years 9 months as per MCA records. was completed.
The CIN of Volpo Pharmaceutical Private Limited is U74899DL1984PTC017519.
Volpo Pharmaceutical Private Limited is headquartered at C-30, Ground Floor Vishal Enclave, New Delhi, Delhi, 110027.
Volpo Pharmaceutical Private Limited was incorporated on 09 February 1984.
The current directors of Volpo Pharmaceutical Private Limited are
The primary industry of Volpo Pharmaceutical Private Limited is Trade.
Volpo Pharmaceutical Private Limited is unlisted.
The authorized capital of Volpo Pharmaceutical Private Limited is ₹5.00 M, and the paid-up capital is ₹0.47 M.
The compliance status of Volpo Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_O.webp)
Company Details
+91-XXXXXXXXXX